Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Regenx Rights Offering Fully Subscribed
-
Rockit™ Apple fired up to Ready. Set. Rockit. into record season
-
Distributor Orders Nexstim NBS System 5 for European Hospital
-
Subsea7 share repurchases
-
Shell plc First Quarter 2024 Euro and GBP Equivalent Dividend Payments
-
-
Transaction in Own Shares
-
Fingerprint Cards AB (publ) will present at Aktiedagarna in Stockholm on June 12, 2024
-
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study
-
Mini Harambe uses a Revolutionary Force for Wildlife and Rainforest Conservation
-
Neorejuvenation Explores University Collaborations to Study Belief Change and Neuroplasticity
-
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Viridien launches new brand to accelerate growth as an advanced technology company
-
Andrew Wilkinson Announces Philanthropic and Personal Transfer of Up to 3,100,000 Shares
-
InsFollowPro.com Announces Launch of AI-Powered Instagram Growth Solutions
-
Arrive in Style and Comfort By Using Toronto Airport Limo Service
-
What Are the Long-Term Benefits of Consistent Physiotherapy?
-
DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)
-
Frankie Picasso, Executive Director of Girl Power USA, Receives the Women of the Decade Award from Women Economic Forum
-
Build-A-Bear Celebrates International Day of Play with 'The Stuff You Love': Free Lil Cub Bears, Heartwarming Donations and Fun for Kids
-
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
-
HIVE Digital Announces May 2024 Bitcoin Production, HODL Grew 3% to 2,451 Bitcoins, Maintained Positive Operating Margin After April Halving and Announces the Acquisition of 1,000 New Bitmain S21 Pro
-
Start of Day Message
-
IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
-
Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
-
Corbion reports the progress of its € 20 million share buyback program 3 June – 7 June 2024
-
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer
-
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
-
Pressidium® Introduces New Hosting Plans and Global Data Centers
-
Yuki Tsunoda to Continue Competing in F1 for the 2025 Season with VISA Cash App RB Formula One Team
-
Edison Lithium Announces Termination of LOI for Sale of Majority Stake in Argentinian Lithium Properties
-
Food Logistics Names Covenant Logistics Group as Recipient of 2024 Top 3PL & Cold Storage Providers Award
-
e.l.f. SKIN Debuts “Peculiar Behavior” Campaign Starring Jameela Jamil as Highly Requested Bronzing Drops Land at Retailers Globally
-
BCG Appoints Dr. Nikolaus Lang Global Leader of BCG Henderson Institute
-
Griffin Global Asset Management Extends and Upsizes Senior Unsecured Revolving Credit Facility to $1.2 Billion
-
PROOF Hard Ice Cream Plays to Crowds at Summerfest 2024
-
InsFollowPro.com Announces Launch of AI-Powered Instagram Growth Solutions
-
Dongfeng Algeria Head Office Opened, Making New Progress in Opening up the African Market
-
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's Disease
-
Mitsubishi Electric Ships Two New SBD-embedded SiC-MOSFET Modules
-
SMC Enters into Acquisition Agreement to Purchase 100% of the Assets of ChainTrade Ltd. Launches AI-Powered Research Platform
-
Qiangli Jucai Lights Up Nasdaq Screen in Times Square, Showcasing Its No. 1 Global Sales Rank in LED Market
-
Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global Challenges
-
Glass Lewis Endorses Palliser’s Proposal for Keisei’s AGM
-
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
-
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
-
Energy Transitions Commission says countries can triple climate ambition by COP30
-
REPEAT – EnviroGold Global Closes First Tranche of Private Placement
